Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN55,6255,64-2,83
Msft-0,19
Nokia3,90553,960,49
IBM0,99
Mercedes-Benz Group AG57,8257,843,27
PFE0,14
27.09.2024 0:38:43
Indexy online
AD Index online
select
AD Index online
 

  • 26.09.2024 22:00:00
Omnicell Inc (OMCL.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
42,33 -0,52 -0,22 391 619
After-hours26.09.2024 23:20:00
Poslední obchod Nákup / Prodej Změna (%) Změna (USD)
42,33 - - -0,52 -0,22
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 27.09.2024
Popis společnosti
Obecné informace
Název společnostiOmnicell Inc
TickerOMCL
Kmenové akcie:Ordinary Shares
RICOMCL.O
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.12.2023 3 650
Akcie v oběhu k 30.04.2024 45 923 492
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice4220 NORTH FREEWAY
MěstoFORT WORTH
PSČ76137
ZeměUnited States
Kontatní osobaKathleen Nemeth
Funkce kontaktní osobyVice President, Investor Relations
Telefon16 502 516 100
Fax16502516266

Business Summary: Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Omnicell Inc revenues decreased 15% to $246.2M. Net loss increased 5% to $15.7M. Revenues reflect Services and other revenues segment decrease of 33% to $111.1M, United States segment decrease of 15% to $218.2M, Rest of the World segment decrease of 19% to $28M. Higher net loss reflects Restructuring Charges & Provisions increase from $144K to $2.7M (expense).
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Medical Software & Technology Services
RBSS2004Healthcare Facilities
MGINDUSTRYSoftware & Programming
MGSECTORTechnology
NAICSCustom Computer Programming Services
NAICSSoftware Publishers
NAICSComputing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
NAICS2007Custom Computer Programming Services
NAICS2007Software Publishers
NAICS2007Data Processing, Hosting, and Related Services
NAICS1997Custom Computer Programming Services
NAICS1997Software Publishers
NAICS1997Data Processing Services
SICElectronic Computers
SICComputer Programming Services
SICPrepackaged Software
SICData Processing And Preparation



  • Poslední aktualizace: 27.09.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerRandall Lipps6616.10.2002
Chief Financial Officer, Executive Vice PresidentNchacha Etta5301.06.202301.06.2023
Executive Vice President and Chief Legal and Administrative OfficerCorey Manley46
Senior Vice President, Chief Accounting Officer, Corporate ControllerJoseph Spears6230.01.2018
Chief Accounting Officer, Vice PresidentBrian Nutt5431.05.202431.05.2024